237 related articles for article (PubMed ID: 30245386)
1. Bioimaging predictors of rilpivirine biodistribution and antiretroviral activities.
Ottemann BM; Helmink AJ; Zhang W; Mukadam I; Woldstad C; Hilaire JR; Liu Y; McMillan JM; Edagwa BJ; Mosley RL; Garrison JC; Kevadiya BD; Gendelman HE
Biomaterials; 2018 Dec; 185():174-193. PubMed ID: 30245386
[TBL] [Abstract][Full Text] [Related]
2. Rod-shape theranostic nanoparticles facilitate antiretroviral drug biodistribution and activity in human immunodeficiency virus susceptible cells and tissues.
Kevadiya BD; Ottemann B; Mukadam IZ; Castellanos L; Sikora K; Hilaire JR; Machhi J; Herskovitz J; Soni D; Hasan M; Zhang W; Anandakumar S; Garrison J; McMillan J; Edagwa B; Mosley RL; Vachet RW; Gendelman HE
Theranostics; 2020; 10(2):630-656. PubMed ID: 31903142
[TBL] [Abstract][Full Text] [Related]
3. Europium sulfide nanoprobes predict antiretroviral drug delivery into HIV-1 cell and tissue reservoirs.
Herskovitz J; Hasan M; Machhi J; Mukadam I; Ottemann BM; Hilaire JR; Woldstad C; McMillan J; Liu Y; Seravalli J; Sarella A; Gendelman HE; Kevadiya BD
Nanotheranostics; 2021; 5(4):417-430. PubMed ID: 33972918
[No Abstract] [Full Text] [Related]
4. Multimodal Theranostic Nanoformulations Permit Magnetic Resonance Bioimaging of Antiretroviral Drug Particle Tissue-Cell Biodistribution.
Kevadiya BD; Woldstad C; Ottemann BM; Dash P; Sajja BR; Lamberty B; Morsey B; Kocher T; Dutta R; Bade AN; Liu Y; Callen SE; Fox HS; Byrareddy SN; McMillan JM; Bronich TK; Edagwa BJ; Boska MD; Gendelman HE
Theranostics; 2018; 8(1):256-276. PubMed ID: 29290806
[TBL] [Abstract][Full Text] [Related]
5. Development of europium doped core-shell silica cobalt ferrite functionalized nanoparticles for magnetic resonance imaging.
Kevadiya BD; Bade AN; Woldstad C; Edagwa BJ; McMillan JM; Sajja BR; Boska MD; Gendelman HE
Acta Biomater; 2017 Feb; 49():507-520. PubMed ID: 27916740
[TBL] [Abstract][Full Text] [Related]
6. Creation of a long-acting rilpivirine prodrug nanoformulation.
Hilaire JR; Bade AN; Sillman B; Gautam N; Herskovitz J; Dyavar Shetty BL; Wojtkiewicz MS; Szlachetka A; Lamberty BG; Sravanam S; Fox HS; Alnouti Y; Dash PK; McMillan JM; Edagwa BJ; Gendelman HE
J Control Release; 2019 Oct; 311-312():201-211. PubMed ID: 31491432
[TBL] [Abstract][Full Text] [Related]
7. Magnetic resonance imaging of folic acid-coated magnetite nanoparticles reflects tissue biodistribution of long-acting antiretroviral therapy.
Li T; Gendelman HE; Zhang G; Puligujja P; McMillan JM; Bronich TK; Edagwa B; Liu XM; Boska MD
Int J Nanomedicine; 2015; 10():3779-90. PubMed ID: 26082630
[TBL] [Abstract][Full Text] [Related]
8. Rilpivirine-associated aggregation-induced emission enables cell-based nanoparticle tracking.
Mukadam IZ; Machhi J; Herskovitz J; Hasan M; Oleynikov MD; Blomberg WR; Svechkarev D; Mohs AM; Zhou Y; Dash P; McMillan J; Gorantla S; Garrison J; Gendelman HE; Kevadiya BD
Biomaterials; 2020 Feb; 231():119669. PubMed ID: 31865227
[TBL] [Abstract][Full Text] [Related]
9. Long-Acting Rilpivirine (RPV) Preexposure Prophylaxis Does Not Inhibit Vaginal Transmission of RPV-Resistant HIV-1 or Select for High-Frequency Drug Resistance in Humanized Mice.
Melody K; Roy CN; Kline C; Cottrell ML; Evans D; Shutt K; Pennings PS; Keele BF; Bility M; Kashuba ADM; Ambrose Z
J Virol; 2020 Mar; 94(8):. PubMed ID: 31969438
[TBL] [Abstract][Full Text] [Related]
10. Virus-Mimicking Polymer Nanoparticles Targeting CD169
Eshaghi B; Fofana J; Nodder SB; Gummuluru S; Reinhard BM
ACS Appl Mater Interfaces; 2022 Jan; 14(2):2488-2500. PubMed ID: 34995059
[TBL] [Abstract][Full Text] [Related]
11. Small magnetite antiretroviral therapeutic nanoparticle probes for MRI of drug biodistribution.
Guo D; Li T; McMillan J; Sajja BR; Puligujja P; Boska MD; Gendelman HE; Liu XM
Nanomedicine (Lond); 2014 Jul; 9(9):1341-52. PubMed ID: 23905578
[TBL] [Abstract][Full Text] [Related]
12. Long-acting slow effective release antiretroviral therapy.
Edagwa B; McMillan J; Sillman B; Gendelman HE
Expert Opin Drug Deliv; 2017 Nov; 14(11):1281-1291. PubMed ID: 28128004
[TBL] [Abstract][Full Text] [Related]
13. Endosomal trafficking of nanoformulated antiretroviral therapy facilitates drug particle carriage and HIV clearance.
Guo D; Zhang G; Wysocki TA; Wysocki BJ; Gelbard HA; Liu XM; McMillan JM; Gendelman HE
J Virol; 2014 Sep; 88(17):9504-13. PubMed ID: 24920821
[TBL] [Abstract][Full Text] [Related]
14. Quantitative magnetic resonance and SPECT imaging for macrophage tissue migration and nanoformulated drug delivery.
Gorantla S; Dou H; Boska M; Destache CJ; Nelson J; Poluektova L; Rabinow BE; Gendelman HE; Mosley RL
J Leukoc Biol; 2006 Nov; 80(5):1165-74. PubMed ID: 16908517
[TBL] [Abstract][Full Text] [Related]
15. Design, formulation and evaluation of novel dissolving microarray patches containing a long-acting rilpivirine nanosuspension.
Mc Crudden MTC; Larrañeta E; Clark A; Jarrahian C; Rein-Weston A; Lachau-Durand S; Niemeijer N; Williams P; Haeck C; McCarthy HO; Zehrung D; Donnelly RF
J Control Release; 2018 Dec; 292():119-129. PubMed ID: 30395897
[TBL] [Abstract][Full Text] [Related]
16. CCR5 Decorated Rilpivirine Lipid Nanoparticles Build Myeloid Drug Depots Which Sustains Antiretroviral Activities.
Gendelman HE; Patel M; Panja S; Zaman LA; Yeapuri P; Bhattarai S; Gorantla S; Chang L; Heredia A; Walczak P; Cohen S; Kevadiya B
Res Sq; 2024 Jun; ():. PubMed ID: 38883780
[TBL] [Abstract][Full Text] [Related]
17. Prevalence of Rilpivirine and Etravirine Resistance Mutations in HIV-1 Subtype C-Infected Patients Failing Nevirapine or Efavirenz-Based Combination Antiretroviral Therapy in Botswana.
Diphoko T; Gaseitsiwe S; Kasvosve I; Moyo S; Okatch H; Musonda R; Wainberg M; Makhema J; Marlink R; Novitsky V; Essex M
AIDS Res Hum Retroviruses; 2018 Aug; 34(8):667-671. PubMed ID: 29732907
[TBL] [Abstract][Full Text] [Related]
18. Mononuclear phagocyte intercellular crosstalk facilitates transmission of cell-targeted nanoformulated antiretroviral drugs to human brain endothelial cells.
Kanmogne GD; Singh S; Roy U; Liu X; McMillan J; Gorantla S; Balkundi S; Smith N; Alnouti Y; Gautam N; Zhou Y; Poluektova L; Kabanov A; Bronich T; Gendelman HE
Int J Nanomedicine; 2012; 7():2373-88. PubMed ID: 22661891
[TBL] [Abstract][Full Text] [Related]
19. Formulation and pharmacology of long-acting rilpivirine.
Williams PE; Crauwels HM; Basstanie ED
Curr Opin HIV AIDS; 2015 Jul; 10(4):233-8. PubMed ID: 26049947
[TBL] [Abstract][Full Text] [Related]
20. Modelling the intradermal delivery of microneedle array patches for long-acting antiretrovirals using PBPK.
Rajoli RKR; Flexner C; Chiong J; Owen A; Donnelly RF; Larrañeta E; Siccardi M
Eur J Pharm Biopharm; 2019 Nov; 144():101-109. PubMed ID: 31525446
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
